Artur Machlenkin
Directeur Technique/Scientifique/R&D chez PLURI INC.
Profil
Artur Machlenkin is currently the Chief Scientific Officer at Pluri, Inc. He previously worked as the Chief Executive Officer at Pantheon Biosciences Ltd.
and as the Head-Immuno Oncology at Compugen Usa, Inc. Dr. Machlenkin holds a doctorate degree from the Weizmann Institute of Science.
Postes actifs de Artur Machlenkin
| Sociétés | Poste | Début |
|---|---|---|
| PLURI INC. | Directeur Technique/Scientifique/R&D | 01/05/2022 |
Anciens postes connus de Artur Machlenkin
| Sociétés | Poste | Fin |
|---|---|---|
| Compugen Usa, Inc. | Corporate Officer/Principal | - |
Pantheon Biosciences Ltd.
 Pantheon Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Pantheon Biosciences Ltd. is an Israeli company that develops molecular therapies and tools. The company is based in Yavne, Israel and was founded in 2017. | Directeur Général | - |
Formation de Artur Machlenkin
| Weizmann Institute of Science | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PLURI INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Compugen Usa, Inc. | |
Pantheon Biosciences Ltd.
Pantheon Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Pantheon Biosciences Ltd. is an Israeli company that develops molecular therapies and tools. The company is based in Yavne, Israel and was founded in 2017. | Commercial Services |
